Elsa Chui Ying Yan

Elsa Chui Ying Yan

Auto-generated profile, based on publicly available information

Elsa Chui Ying Yan

Department of Chemistry, Yale University, New Haven, CT 06520, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2014 in Chemical Reviews
Verified
Journal Article
Open access
EYElsa C. Y. Yan
Elsa C. Y. Yan
LFLi Fu
Li Fu
ZWZhuguang Wang
Zhuguang Wang
WLWei Liu
Wei Liu

12 July 2010 in ACS Nano
Verified
Journal Article
Closed access
WWWeitai Wu
Weitai Wu
NMNivedita Mitra
Nivedita Mitra
EYElsa C. Y. Yan
Elsa C. Y. Yan
SZshuiqin zhou
shuiqin zhou

2 May 2011 in Journal of the American Chemical Society
Verified
Journal Article
Open access
LFLi Fu
Li Fu
JLJian Liu
Jian Liu
EYElsa C. Y. Yan
Elsa C. Y. Yan
In situ and real-time characterization of protein secondary structures at interfaces is important in biological and bioengineering sciences, yet remains technically challenging. In this study, we used chiral sum frequency generation (SFG) spectroscopy to establish a set of vibrational optical markers for characterizing protein secondary structures at interfaces. We discovered that the N–H stretches along the peptide backbones of α-helices can be detected in chiral SFG spectra. We further observed that the chiral vibrational signatures of the N–H stretch together with the peptide amide I are unique to α-helix, β-sheet, and random coil at interfaces. Using these chiral vibrational signatures, we studied the aggregation of human islet amyloid polypeptide (hIAPP), which is implicated in type II diabetes. We observed in situ and in real time the misfolding of hIAPP from random coils to α-helices and then β-sheets upon interaction with a lipid–water interface. Our findings show that chiral SFG spectroscopy is a powerful tool to follow changes in protein conformations at interfaces and identify interfacial protein secondary structures that elude conventional techniques.

1 August 1996 in Chemical Physics Letters
Verified
Journal Article
Closed access
HWH. Wang
H. Wang
EYE.C.Y. Yan
E.C.Y. Yan
EBE. Borguet
E. Borguet
KEK.B. Eisenthal
K.B. Eisenthal

29 July 1998 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
EYElsa C. Y. Yan
Elsa C. Y. Yan
YLYan Liu
Yan Liu
KEKenneth B. Eisenthal
Kenneth B. Eisenthal

1 February 2009 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
SAShivani Ahuja
Shivani Ahuja
VHViktor Hornak
Viktor Hornak
EYElsa C Y Yan
Elsa C Y Yan
NSNatalie Syrett
Natalie Syrett
JGJoseph A Goncalves
Joseph A Goncalves
MEMarkus Eilers
Markus Eilers
Endonuclease V can initiate the repair of deaminated purine bases by recognizing them and hydrolyzing the second phosphodiester bond on their 3′ side. Now the crystal structures of endonuclease V in complex with its substrate and its product reveal a wedge motif acting as a minor groove–damage sensor and a pocket to recognize the lesion; the enzyme remains tightly bound to the 5′ phosphate product, perhaps to hand it over to downstream repair factors. The second extracellular loop (EL2) of rhodopsin forms a cap over the binding site of its photoreactive 11-cis retinylidene chromophore. A crucial question has been whether EL2 forms a reversible gate that opens upon activation or acts as a rigid barrier. Distance measurements using solid-state 13C NMR spectroscopy between the retinal chromophore and the β4 strand of EL2 show that the loop is displaced from the retinal binding site upon activation, and there is a rearrangement in the hydrogen-bonding networks connecting EL2 with the extracellular ends of transmembrane helices H4, H5 and H6. NMR measurements further reveal that structural changes in EL2 are coupled to the motion of helix H5 and breaking of the ionic lock that regulates activation. These results provide a comprehensive view of how retinal isomerization triggers helix motion and activation in this prototypical G protein–coupled receptor.